Skip to main content

A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV

Research Question:
Is the drug, Sisunatovir, safe in children who have a chest infection caused by RSV?

Basic Study Information

The purpose of the study is to learn about the safety and amount of sisunatovir in the blood of infants and children up to age 60 months. These children have Lower Respiratory Tract Infection (LRTI) caused by Respiratory Syncytial Virus (RSV). LRTI is the infection to the lower airways such as lungs. This study will help inform the amount of sisunatovir to be used in future studies of sisunatovir in children. This study is seeking for participants who: - Are 1 day to less than or equal to 60 months of age - weigh more than or equal to 2.5 kilograms to less than or equal to 23 kilograms. - Have been tested to have RSV by medical tests. - show signs of LRTI. Up to 7 visits are required for the study. Some of these visits include checking participants health over the phone and/or a visit at home.

Location: University of Rochester Medical Center
Study Reference #: STUDY00008652

Lead Researcher (Principal Investigator)

Lead Researcher:  Jennifer Nayak

Study Contact Information

Study Coordinator: Michelle Heiman
Phone: (585) 275-2107

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search